Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic Cardiomyopathy
Source: Nih-reporter ·
Leveraging Large-Scale Biobanks to Discover and Define Rare Variant Effects in Hypertrophic Cardiomyopathy — VANDERBILT UNIVERSITY MEDICAL CENTER
Key dates
- Award date
- August 7, 2026
- Performance start
- August 1, 2024
- Performance end
- July 31, 2028
Details
- Agency
- National Heart Lung and Blood Institute
- Buyer type
- Federal
- Jurisdiction
- Tennessee (TN)
- Category
- Administrative
- Value
- $654,551
- Set-aside
- —
- NAICS
- —
- PSC
- —
- Source
- nih-reporter
Who is this buyer
Organization
Source: Provider universeNot matched to a provider record yet.
Buying history
Source: Solicitation records- Records41 total
- Opportunities / awards0 / 0
- Value range$50,114 – $1,483,340
- ActiveAugust 11, 2026 – August 11, 2026
What they buy
- Administrative (36)
- Clinical (5)
Financial highlights
Source: IRS Form 990No 990 filing on record.
Who holds their work today
Source: Solicitation records · awardsNo awards on record for this buyer.
What they're trying to solve
Source: AI-generatedNo brief written for this buyer yet.
Also open from this buyer
Source: Solicitation recordsNo other open opportunities on record.
Ways to meet this buyer
Source: Solicitation records · event noticesUpcoming
No upcoming events on record.
View source document →
Source link on nih-reporter.